During the recent session, Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares were 0.71 million, with the beta value of the company hitting 0.20. At the last check today, the stock’s price was $0.28, reflecting an intraday loss of -11.81% or -$0.04. The company’s market capitalization is $2.37M, and the average intraday trading volume over the past 10 days was 0.53 million shares, and the average trade volume was 3.24 million shares over the past three months.

Revelation Biosciences Inc (REVB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. REVB has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.43.

Revelation Biosciences Inc (NASDAQ:REVB) trade information

Revelation Biosciences Inc (REVB) registered a -11.81% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -11.81% in intraday trading to $0.28, hitting a weekly high. The stock’s 5-day price performance is -31.37%, and it has moved by -3.59% in 30 days. Based on these gigs, the overall price performance for the year is -97.13%. The short interest in Revelation Biosciences Inc (NASDAQ:REVB) is 0.24 million shares and it means that shorts have 0.1 day(s) to cover.

Revelation Biosciences Inc (REVB) estimates and forecasts

Statistics show that Revelation Biosciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. Revelation Biosciences Inc (REVB) shares have gone down -82.76% during the last six months, with a year-to-date growth rate more than the industry average at 79.76% against 16.50.

While earnings are projected to return -1311.32% in 2025.

REVB Dividends

Revelation Biosciences Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders

Revelation Biosciences Inc insiders own 0.03% of total outstanding shares while institutional holders control 11.37%, with the float percentage being 11.37%.

Also, the Mutual Funds coming in first place with the largest holdings of Revelation Biosciences Inc (REVB) shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 8.02 shares. This amounts to just over 0.10 percent of the company’s overall shares, with a $2250.0 market value. The same data shows that the other fund manager holds slightly less at 2.94, or about 0.04% of the stock, which is worth about $825.0.